Literature DB >> 11819769

Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.

A Morgner1, S Miehlke, M Stolte, A Neubauer, B Alpen, C Thiede, H Klann, F X Hierlmeier, C Ell, G Ehninger, E Bayerdörffer.   

Abstract

AIM: To report 3 of 120 patients on the German MALT lymphoma trial with H. pylori associated gastric MALT lymphoma who developed early gastric cancer 4 and 5 years, after complete lymphoma remission following cure of H. pylori infection. PATIENTS AND
RESULTS: Three patients (two men, 74 and 70 years; one women, 77 years) with H. pylori-associated low-grade MALT lymphoma achieved complete lymphoma remission after being cured. Surveillance endoscopies were performed twice a year in accordance to the protocol. Four years after complete lymphoma remission in two patients, and after 5 years in the other, early gastric adenocarcinoma of the mucosa-type, type IIa and type IIc, respectively, was detected, which were completely removed by endoscopic mucosa resection. In one patient, the gastric cancer was diagnosed at the same location as the previous MALT lymphoma, in the other patients it was detected at different sites of the stomach distant from location of the previous MALT lymphoma. The patients were H. pylori negative during the whole follow-up time.
CONCLUSION: These findings strengthen the importance of regular Long-term follow-up endoscopies in patients with complete remission of gastric MALT lymphoma after cure of H. pylori infection. Furthermore, gastric adenocarcinoma may develop despite eradication of H. pylori.

Entities:  

Mesh:

Year:  2001        PMID: 11819769      PMCID: PMC4723531          DOI: 10.3748/wjg.v7.i2.248

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

Review 1.  [Gastric adenocarcinoma following the treatment of a gastric non-Hodgkin's lymphoma].

Authors:  C García-Girón; J Feliu; A Ordóñez; P Zamora; S Blanco; M J Sánchez; M González Barón
Journal:  Med Clin (Barc)       Date:  1990-11-24       Impact factor: 1.725

2.  Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Authors:  S Miehlke; C Kirsch; B Dragosics; M Gschwantler; G Oberhuber; D Antos; P Dite; J Läuter; J Labenz; A Leodolter; P Malfertheiner; A Neubauer; G Ehninger; M Stolte; E Bayerdörffer
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.

Authors:  D Forman; D G Newell; F Fullerton; J W Yarnell; A R Stacey; N Wald; F Sitas
Journal:  BMJ       Date:  1991-06-01

4.  High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma.

Authors:  E Zucca; G Pinotti; E Roggero; M A Comi; A Pascarella; C Capella; E Pedrinis; F Cavalli
Journal:  Ann Oncol       Date:  1995-09       Impact factor: 32.976

5.  Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients.

Authors:  S Nakamura; K Aoyagi; S Iwanaga; T Yao; M Tsuneyoshi; M Fujishima
Journal:  Cancer       Date:  1997-03-15       Impact factor: 6.860

Review 6.  Synchronous adenocarcinoma and low grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of the stomach.

Authors:  A C Wotherspoon; P G Isaacson
Journal:  Histopathology       Date:  1995-10       Impact factor: 5.087

7.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

8.  Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.

Authors: 
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

9.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

Review 10.  Helicobacter pylori phenotypes associated with peptic ulceration.

Authors:  M J Blaser
Journal:  Scand J Gastroenterol Suppl       Date:  1994
View more
  26 in total

1.  Apoptosis of human gastric adenocarcinoma cells induced by beta-ionone.

Authors:  Jia-Ren Liu; Bing-Qing Chen; Bao-Feng Yang; Hong-Wei Dong; Chang-Hao Sun; Qi Wang; Guo Song; You-Qiang Song
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  Clinicopathologic features of surgically resected primary gastric lymphoma.

Authors:  Seong-Ho Kong; Min-A Kim; Do-Joong Park; Hyuk-Joon Lee; Hye-Seung Lee; Chul-Woo Kim; Han-Kwang Yang; Dae-Seog Heo; Kuhn-Uk Lee; Kuk-Jin Choe
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

3.  Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study.

Authors:  L Cai; S Z Yu; Z F Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Authors:  S Miehlke; C Kirsch; B Dragosics; M Gschwantler; G Oberhuber; D Antos; P Dite; J Läuter; J Labenz; A Leodolter; P Malfertheiner; A Neubauer; G Ehninger; M Stolte; E Bayerdörffer
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  Gastric adenocarcinoma in a patient re-infected with H. pylori after regression of MALT lymphoma with successful anti-H. pylori therapy and gastric resection: a case report.

Authors:  Uday C Ghoshal; Debashish Guha; Santu Bandyopadhyay; Chiranjib Pal; Srikanta Chakraborty; Ujjala Ghoshal; Tamal K Ghosh; Bhaskar B Pal; Prabir K Banerjee
Journal:  BMC Gastroenterol       Date:  2002-03-14       Impact factor: 3.067

6.  The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis.

Authors:  Xi-Xian Yao; Lei Yin; Zhong-Cheng Sun
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Expression of Helicobacter pylori Hsp60 protein and its immunogenicity.

Authors:  Yang Bai; Liang-Ren Li; Ji-De Wang; Ye Chen; Jian-Feng Jin; Zhao-Shan Zhang; Dian-Yuan Zhou; Ya-Li Zhang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

8.  Construction of expression systems for flaA and flaB genes of Helicobacter pylori and determination of immunoreactivity and antigenicity of recombinant proteins.

Authors:  Jie Yan; Shao-Hui Liang; Ya-Fei Mao; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity.

Authors:  Ya-Fei Mao; Jie Yan
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.